论文部分内容阅读
目的:探究小剂量尿激酶联合低分子肝素钙治疗急性心肌梗死的临床效果。方法:选择在我院接受治疗的168例急性心肌梗死患者为研究对象,随机分为观察组和对照组,观察和比较两组患者的临床治疗效果。结果:观察组的总体临床治疗效果显著优于对照组,观察组患者的12h血管再通率显著高于对照组,且观察组患者出血、心律失常等并发症的发生率也显著低于对照组,两组数据差异具有统计学意义(P<0.05)。结论:小剂量尿激酶联合低分子肝素钙治疗急性心肌梗死可有效提高患者冠状动脉血管的再通率,减少并发症的发生,具有临床推广和应用价值。
Objective: To investigate the clinical effect of low-dose urokinase combined with low molecular weight heparin on acute myocardial infarction. Methods: A total of 168 acute myocardial infarction patients who were treated in our hospital were selected as study subjects and randomly divided into observation group and control group. The clinical effects of two groups were observed and compared. Results: The overall clinical curative effect of the observation group was significantly better than that of the control group. The rate of vascular recanalization at 12h in the observation group was significantly higher than that in the control group, and the complication rates of bleeding, arrhythmia and other complications in the observation group were significantly lower than those in the control group , The difference between the two groups was statistically significant (P <0.05). Conclusion: The combination of low-dose urokinase and low-molecular-weight heparin in the treatment of acute myocardial infarction can effectively improve the recanalization rate and reduce the incidence of complications in patients with coronary artery disease, and has clinical application value.